[Neurorehabilitation treatment of amyotrophic lateral sclerosis].
OBJECTIVE
To carry out a review of the literature with the aim of defining, evaluating, establishing and making more widely known the value of neurorehabilitation therapy in the different phases of the course of amyotrophic lateral sclerosis (ALS). Special emphasis will be given to the role this type of treatment plays in improving both survival rates and these patients' functional independence and quality of life.


METHODS
Although ALS is a disease that follows an unrelenting course, patients' quality of life, and even their survival time, can be changed dramatically with suitable medical management. Neurorehabilitation therapy consists of an integral process carried out by an interdisciplinary team that includes the basic pharmacological treatment, symptomatic treatment of the associated problems and rehabilitation therapy, the aim being to prolong the functional capacity of these patients and to promote their independence. Its ultimate goal is to ensure the highest possible quality of life throughout the whole health care process.


CONCLUSIONS
Until a cure is found for ALS, neurorehabilitation therapy is clearly today's most promising therapeutic option as far as improving these patients' quality of life, health and survival rates is concerned. This treatment should not only involve the medical care of the patient, but also provide the appropriate technical aids and home help, together with training and preparation of both the main caregiver and the patient's family. This instruction should cover the whole period from the moment the disease is diagnosed to its terminal phase.
Orient-López
F
F
Unidad de Daño Cerebral, Institut Guttmann, Hospital de Neurorehabilitación, 08916 Badalona, España. forient@guttmann.com
Terré-Boliart
R
R
Guevara-Espinosa
D
D
Bernabeu-Guitart
M
M
D000690:Amyotrophic Lateral Sclerosis / Q000175:diagnosis / Q000534:rehabilitation* / Q000628:therapy; D006801:Humans